Search
Leader | 00000nz a2200037oc 45 0 | ||
---|---|---|---|
001 | DNB|1343700353 (VIAF cluster) | ||
003 | DNB | ||
005 | 20241001135120.0 | ||
008 | 241001n||aznnnaabn | aaa |c | ||
035 | ‡a (DNB)1343700353 | ||
024 | 7 | ‡a 1343700353 ‡0 http://d-nb.info/gnd/1343700353 ‡2 gnd | |
035 | ‡a (DE-101)1343700353 | ||
035 | ‡a (DE-588)1343700353 | ||
040 | ‡a DE-206 ‡c DE-206 ‡9 r:DE-206 ‡b ger ‡d 0206 ‡e rda | ||
042 | ‡a gnd3 | ||
043 | ‡c XD-US | ||
075 | ‡b p ‡2 gndgen | ||
075 | ‡b piz ‡2 gndspec | ||
079 | ‡a g ‡q f | ||
100 | 1 | ‡a D'Souza, Arielle | |
400 | 1 | ‡a Souza, Arielle d' | |
510 | 2 | ‡a Institute for Progress ‡g Washington, DC ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡w r ‡i Affiliation ‡e Affiliation | |
548 | ‡a 2024- ‡4 datw ‡4 https://d-nb.info/standards/elementset/gnd#periodOfActivity ‡w r ‡i Wirkungsdaten | ||
672 | 0 | ‡a Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines? ‡f 2024 | |
909 | ‡a (gnd) 1343700353 ‡9 1 | ||
947 | ‡a US ‡9 1 | ||
996 | ‡2 ISNI|000000044076040X | ||
996 | ‡2 BAV|495_162571 | ||
996 | ‡2 PTBNP|211749 | ||
996 | ‡2 LC|n 84104225 | ||
996 | ‡2 PTBNP|1525163 | ||
996 | ‡2 J9U|987007341189405171 | ||
996 | ‡2 LC|n 83057105 | ||
996 | ‡2 LC|no2007104394 | ||
996 | ‡2 PTBNP|1807495 | ||
996 | ‡2 LIH|LNB:CE_t_1;=BT | ||
996 | ‡2 WKP|Q78514472 | ||
996 | ‡2 NII|DA03134193 | ||
996 | ‡2 BLBNB|000360344 | ||
996 | ‡2 LC|no2022131690 | ||
996 | ‡2 BNF|13465773 | ||
996 | ‡2 WKP|Q86116236 | ||
996 | ‡2 BLBNB|000360725 | ||
996 | ‡2 SUDOC|196075998 | ||
996 | ‡2 ISNI|0000000383757385 | ||
996 | ‡2 ISNI|0000000045026192 | ||
996 | ‡2 CAOONL|ncf11168433 | ||
996 | ‡2 WKP|Q96140505 | ||
996 | ‡2 BLBNB|000603125 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |